{
    "nctId": "NCT02652975",
    "briefTitle": "Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium",
    "officialTitle": "Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Neoplasms, Endothelial Dysfunction, Cardiovascular Disease, Metabolic Syndrome",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 76,
    "primaryOutcomeMeasure": "Changes in endothelial dysfunction evaluated using plethysmography.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* women referred to receive adjuvant chemotherapy for primary operable non-metastatic breast cancer\n\nExclusion Criteria:\n\n* former og actual use of cytostatics\n* pregnancy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}